P009 “High-risk” patients with aggressive non-Hodgkin lymphoma should benefit from autologous stem cell transplantation in first remission (single-centre experience)

✍ Scribed by S. Genadieva Stavrik; L. Cevreska; Z. Stojanoski; A. Pivkova; A. Stojanovik; S. Krstevska Balkanov; O. Karanfilski; B. Georgievski

• Book ID: 108424646
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 50 KB
• Volume: 21
• Category: Article
• ISSN: 0268-960X
• DOI: 10.1016/s0268-960x(07)70082-6